Arbutus Biopharma Corp Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q1 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Arbutus Biopharma Corp quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2013 to Q1 2024.
  • Arbutus Biopharma Corp Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was $11.7M, a 29.9% decline year-over-year.
  • Arbutus Biopharma Corp annual Net Cash Provided by (Used in) Investing Activities for 2023 was $50.8M.
  • Arbutus Biopharma Corp annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$74.9M, a 491% decline from 2021.
  • Arbutus Biopharma Corp annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$12.7M, a 15% increase from 2020.
Net Cash Provided by (Used in) Investing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $11.7M -$4.98M -29.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q1 2023 $16.7M +$76.7M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 -$60.1M -$78.3M -430% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $18.2M +$20.6M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 -$35.1M -$2.4M -$63.4M -104% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $28.3M -$58.8M -$91M -283% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 $119M $16.2M -$8.22M -33.7% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $128M $9.97M -$5.01M -33.4% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $133M $61M +$137M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$4.13M $32.2M +$31.5M +4401% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$35.6M $24.4M +$19.1M +360% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$54.7M $15M +$16.4M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 -$71M -$75.7M -$98.9M -426% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $27.8M $715K -$17K -2.32% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 $27.8M $5.31M +$6.19M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $21.7M -$1.39M +$84M +98.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$62.3M $23.2M +$36.8M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 -$99.1M $732K +$2.54M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$102M -$880K +$16.9M +95% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$119M -$85.4M -$75.1M -727% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$43.4M -$13.6M -$51.1M -136% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $7.68M -$1.8M -$2.86M -271% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $10.5M -$17.7M -$17.3M -3903% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $27.8M -$10.3M +$32.9M +76.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$5.08M $37.5M +$37.9M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 -$43M $1.06M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-22
Q3 2014 -$443K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$43.2M -$43.1M -35932% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$335K -$134K -66.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q2 2013 -$120K Apr 1, 2013 Jun 30, 2013 10-Q 2014-11-07
Q1 2013 -$201K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.